Guillain-Barré Syndrome Variant Occurring After COVID-19 Vaccines According to Two New Annals of Neurology Articles
Degree of recognition
American Neurological Association
With the widespread use of vaccines to protect against infection by the SARS-Cov2 virus, there is intense interest in possible low-frequency but clinically significant complications. Annals of Neurology announces two new research articles, one from India and one from England, both reporting clusters of an unusual variant of Guillain-Barre syndrome characterized by prominent bilateral facial weakness.